FindTrial
Sign In

To see the results of Itraconazole tablets in operated patients of Allergic Fungal Rhinosinositis.

Assessment of the effect of Postoperative oral Itraconazole in prevention of recurrence in adults patients with Allergic Fungal Rhinosinusitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042152
Enrollment
25
Registered
2022-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J019- Acute sinusitis, unspecified

Interventions

Intervention1: Tab Itraconazole: 200mg BD for pod 1 then 200mg OD for 21 days Control Intervention1: Placebo: Dummy tablets for 21 days

Sponsors

All India Institute of Medical Sciences Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients with Allergic fungal rhino-sinusitis undergoing FESS 2. Previously operated cases of chronic allergic rhino-sinusitis undergoing Revision FESS.

Exclusion criteria

Exclusion criteria: 1. Patients with a previous history of sensitivity to Itraconazole 2. Patients who have received post-operative steroids. 3. Patient on immunosuppressive drugs or diagnosis of immunodeficiency disease 4. Patients previously treated with post-operative Itraconazole. 5. Pregnancy. 6. Patients having hepatic dysfunction 7. Patients

Design outcomes

Primary

MeasureTime frame
Recurrence of Allergic fungal rhinosinusitisTimepoint: 6 months post operatively—

Secondary

MeasureTime frame
To compare the outcomes using scoring systems such as SNOT-22, DIPS score, Lund Kennedy score, Lund - Mackay scoreTimepoint: Preoperatively intital assessment will be done; post operative assessment at 6 months—

Countries

India

Contacts

Public ContactDr Bikram Choudhury

All India Institute of Medical Sciences, Jodhpur

comatosebuddha@gmail.com959660099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026